Back to Search
Start Over
Outcome of everolimus based therapy in hormone receptor positive metastatic breast cancer patients after progression on palbociclib combination
- Source :
- Journal of Clinical Oncology. 36:1064-1064
- Publication Year :
- 2018
- Publisher :
- American Society of Clinical Oncology (ASCO), 2018.
-
Abstract
- 1064Background: BOLERO 2 trial showed improved progression free survival (PFS) with everolimus (EV) + exemestane combination over exemestane alone in hormone receptor positive, HER2 non-amplified m...
- Subjects :
- 0301 basic medicine
Oncology
Cancer Research
medicine.medical_specialty
Everolimus
business.industry
Palbociclib
medicine.disease
Metastatic breast cancer
03 medical and health sciences
chemistry.chemical_compound
030104 developmental biology
Exemestane
chemistry
Hormone receptor
Internal medicine
medicine
Progression-free survival
business
neoplasms
medicine.drug
Subjects
Details
- ISSN :
- 15277755 and 0732183X
- Volume :
- 36
- Database :
- OpenAIRE
- Journal :
- Journal of Clinical Oncology
- Accession number :
- edsair.doi...........b0a3b20c6705881edb39612d1e5690b8
- Full Text :
- https://doi.org/10.1200/jco.2018.36.15_suppl.1064